Columbia Research Enhanced Value ETF Rating $26.79 +0.15 (+0.56%) As of 12:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Columbia Research Enhanced Value ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.REVS Aggregate RatingModerate Buy 2.60Holdings in REVS have an aggregate rating of Moderate Buy based on 563 analyst ratings issued in the past year covering 23 companies (40.7% of the portfolio).REVS Aggregate Price Target$26.790.00% DownsideHigh Prediction$26.79Average Prediction$26.79Low Prediction$26.79Holdings in REVS have an aggregate price target of $26.79 and a range of $26.79 to $26.79 covering 23 companies (40.7% of the portfolio).REVS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Columbia Research Enhanced Value ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 REVS Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.35%JPMJPMorgan Chase & Co.$288.88+0.7%4.8272 of 5 stars2.52$288.68 -0.1%23Trending NewsAnalyst Revision2.57%CSCOCisco Systems$71.63+2.5%4.6768 of 5 stars2.76$70.55 -1.5%25Positive NewsUpcoming EarningsAnalyst Forecast2.49%PFEPfizer$24.46+0.9%4.9867 of 5 stars2.39$28.12 15.0%18Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision2.43%XOMExxon Mobil$107.00+1.0%4.7659 of 5 stars2.47$125.26 17.1%19Positive NewsEarnings ReportDividend Announcement2.08%CRMSalesforce$240.27-0.3%4.9039 of 5 stars2.76$348.16 44.9%42Trending NewsInsider Trade1.99%MOAltria Group$64.14+0.9%4.0966 of 5 stars2.00$59.13 -7.8%9Positive NewsAnalyst Forecast1.77%BLKBlackRock$1,121.28+0.8%4.8062 of 5 stars2.86$1,151.21 2.7%14Trending NewsAnalyst Revision1.75%CATCaterpillar$416.71-0.1%4.6852 of 5 stars2.78$444.00 6.5%18Trending NewsEarnings ReportAnalyst Forecast1.70%LOWLowe's Companies$241.53+1.2%4.801 of 5 stars2.58$270.68 12.1%26Positive News1.67%MSMorgan Stanley$143.07+1.5%4.6355 of 5 stars2.47$138.25 -3.4%15Trending NewsAnalyst Revision1.66%GOOGLAlphabet$200.67+2.1%4.1338 of 5 stars2.86$211.53 5.4%43Trending NewsAnalyst ForecastInsider Trade1.47%CCitigroup$92.61+1.5%4.9268 of 5 stars2.67$96.54 4.2%15Trending News1.44%BMYBristol Myers Squibb$45.83+1.0%4.6283 of 5 stars2.24$56.38 23.0%21Positive NewsAnalyst Downgrade1.42%CVSCVS Health$64.92+2.1%4.9985 of 5 stars2.90$75.39 16.1%21Positive News1.36%GOOGAlphabet$201.47+2.1%4.7797 of 5 stars2.77$215.19 6.8%31Trending NewsInsider Trade1.30%UNPUnion Pacific$223.19+0.2%4.8062 of 5 stars2.63$258.21 15.7%27Positive News1.29%CICigna Group$274.23+1.2%5 of 5 stars3.00$377.72 37.7%20Analyst Forecast1.28%QCOMQUALCOMM$147.54+1.1%4.8877 of 5 stars2.43$181.10 22.7%23Positive News1.24%CVXChevron$155.47+1.5%4.412 of 5 stars2.40$164.11 5.6%20Trending NewsEarnings ReportDividend Announcement1.20%NKENIKE$73.82-0.7%4.4452 of 5 stars2.72$78.22 6.0%32Positive NewsDividend Announcement1.16%METAMeta Platforms$762.46+0.1%4.3061 of 5 stars2.98$822.41 7.9%46Trending NewsAnalyst ForecastInsider Trade1.02%CMECME Group$280.67-0.1%4.4394 of 5 stars2.06$261.93 -6.7%16Positive NewsDividend Announcement1.01%AMDAdvanced Micro Devices$172.11-0.2%4.3866 of 5 stars2.79$178.56 3.7%39Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision This page (NYSEARCA:REVS) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredThe Day Silicon DiesThe Day China Left America's Supercomputers in the Dust In 200 seconds, China's quantum computer accomplish...The Oxford Club | SponsoredThis accelerated income plan is solving American's #1 retirement fearThe #1 fear in retirement today? Running out of money. That’s why income expert Tim Plaehn created a simple...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Columbia Research Enhanced Value ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Columbia Research Enhanced Value ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
